| UniProt ID | TMX2_HUMAN | |
|---|---|---|
| UniProt AC | Q9Y320 | |
| Protein Name | Thioredoxin-related transmembrane protein 2 | |
| Gene Name | TMX2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 296 | |
| Subcellular Localization |
Membrane Single-pass type I membrane protein . |
|
| Protein Description | ||
| Protein Sequence | MAVLAPLIALVYSVPRLSRWLAQPYYLLSALLSAAFLLVRKLPPLCHGLPTQREDGNPCDFDWREVEILMFLSAIVMMKNRRSITVEQHIGNIFMFSKVANTILFFRLDIRMGLLYITLCIVFLMTCKPPLYMGPEYIKYFNDKTIDEELERDKRVTWIVEFFANWSNDCQSFAPIYADLSLKYNCTGLNFGKVDVGRYTDVSTRYKVSTSPLTKQLPTLILFQGGKEAMRRPQIDKKGRAVSWTFSEENVIREFNLNELYQRAKKLSKAGDNIPEEQPVASTPTTVSDGENKKDK | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 12 | Phosphorylation | APLIALVYSVPRLSR HHHHHHHHCHHHHHH | 12.56 | 24043423 | |
| 13 | Phosphorylation | PLIALVYSVPRLSRW HHHHHHHCHHHHHHH | 20.40 | 24043423 | |
| 18 | Phosphorylation | VYSVPRLSRWLAQPY HHCHHHHHHHHHHHH | 23.77 | 24043423 | |
| 41 | Ubiquitination | AAFLLVRKLPPLCHG HHHHHHHHCCHHHCC | 58.84 | 27667366 | |
| 50 | Ubiquitination | PPLCHGLPTQREDGN CHHHCCCCCCCCCCC | 30.95 | 33845483 | |
| 73 | Phosphorylation | VEILMFLSAIVMMKN HHHHHHHHHHHHHCC | 12.51 | 20068231 | |
| 75 | Ubiquitination | ILMFLSAIVMMKNRR HHHHHHHHHHHCCCC | 1.51 | 33845483 | |
| 79 | Acetylation | LSAIVMMKNRRSITV HHHHHHHCCCCCEEE | 29.25 | 7710617 | |
| 83 (in isoform 2) | Phosphorylation | - | 21.26 | - | |
| 83 | Phosphorylation | VMMKNRRSITVEQHI HHHCCCCCEEEEEHH | 21.26 | 21406692 | |
| 85 | Phosphorylation | MKNRRSITVEQHIGN HCCCCCEEEEEHHHC | 21.16 | 21406692 | |
| 97 | Phosphorylation | IGNIFMFSKVANTIL HHCHHHHHHHCCCHH | 17.90 | 21406692 | |
| 99 | Ubiquitination | NIFMFSKVANTILFF CHHHHHHHCCCHHHH | 4.87 | 33845483 | |
| 101 | Ubiquitination | FMFSKVANTILFFRL HHHHHHCCCHHHHHH | 30.55 | 22817900 | |
| 106 (in isoform 2) | Ubiquitination | - | 7.31 | 21890473 | |
| 106 | Ubiquitination | VANTILFFRLDIRMG HCCCHHHHHHHHHHH | 7.31 | 27667366 | |
| 113 | Ubiquitination | FRLDIRMGLLYITLC HHHHHHHHHHHHHHH | 11.59 | 33845483 | |
| 116 | Ubiquitination | DIRMGLLYITLCIVF HHHHHHHHHHHHHHH | 9.26 | 33845483 | |
| 121 | Ubiquitination | LLYITLCIVFLMTCK HHHHHHHHHHHHHCC | 2.49 | 33845483 | |
| 124 | Ubiquitination | ITLCIVFLMTCKPPL HHHHHHHHHHCCCCC | 1.60 | 33845483 | |
| 132 | Phosphorylation | MTCKPPLYMGPEYIK HHCCCCCCCCHHHHH | 13.05 | - | |
| 138 | Ubiquitination | LYMGPEYIKYFNDKT CCCCHHHHHHCCCCC | 2.51 | 33845483 | |
| 139 | Ubiquitination | YMGPEYIKYFNDKTI CCCHHHHHHCCCCCC | 42.77 | 22817900 | |
| 144 | Ubiquitination | YIKYFNDKTIDEELE HHHHCCCCCCCHHHH | 48.78 | 21906983 | |
| 144 (in isoform 1) | Ubiquitination | - | 48.78 | 21890473 | |
| 146 | Ubiquitination | KYFNDKTIDEELERD HHCCCCCCCHHHHHH | 8.48 | 33845483 | |
| 155 | Ubiquitination | EELERDKRVTWIVEF HHHHHHHCEEEEEHH | 35.07 | 21963094 | |
| 155 (in isoform 2) | Ubiquitination | - | 35.07 | 21890473 | |
| 165 | Ubiquitination | WIVEFFANWSNDCQS EEEHHHHCCCCCCCH | 37.24 | 33845483 | |
| 169 | Ubiquitination | FFANWSNDCQSFAPI HHHCCCCCCCHHHHE | 26.73 | 33845483 | |
| 175 | Ubiquitination | NDCQSFAPIYADLSL CCCCHHHHEECEEEE | 20.36 | 33845483 | |
| 177 | Ubiquitination | CQSFAPIYADLSLKY CCHHHHEECEEEEEE | 7.94 | 23000965 | |
| 177 (in isoform 2) | Ubiquitination | - | 7.94 | 21890473 | |
| 179 | Ubiquitination | SFAPIYADLSLKYNC HHHHEECEEEEEEEC | 21.59 | 33845483 | |
| 182 | Ubiquitination | PIYADLSLKYNCTGL HEECEEEEEEECCCC | 9.92 | 33845483 | |
| 187 | Ubiquitination | LSLKYNCTGLNFGKV EEEEEECCCCCCCEE | 40.86 | 33845483 | |
| 187 | Phosphorylation | LSLKYNCTGLNFGKV EEEEEECCCCCCCEE | 40.86 | 21712546 | |
| 189 (in isoform 2) | Ubiquitination | - | 2.30 | - | |
| 189 | Ubiquitination | LKYNCTGLNFGKVDV EEEECCCCCCCEEEE | 2.30 | 21963094 | |
| 193 | Acetylation | CTGLNFGKVDVGRYT CCCCCCCEEEECEEC | 30.99 | 25953088 | |
| 193 (in isoform 1) | Ubiquitination | - | 30.99 | 21890473 | |
| 193 | Ubiquitination | CTGLNFGKVDVGRYT CCCCCCCEEEECEEC | 30.99 | 21906983 | |
| 199 | Ubiquitination | GKVDVGRYTDVSTRY CEEEECEECCCCCEE | 11.02 | 33845483 | |
| 200 | Ubiquitination | KVDVGRYTDVSTRYK EEEECEECCCCCEEE | 28.67 | 33845483 | |
| 206 | Phosphorylation | YTDVSTRYKVSTSPL ECCCCCEEEEECCCC | 18.81 | 23312004 | |
| 206 | Ubiquitination | YTDVSTRYKVSTSPL ECCCCCEEEEECCCC | 18.81 | 33845483 | |
| 207 | Ubiquitination | TDVSTRYKVSTSPLT CCCCCEEEEECCCCH | 26.81 | 33845483 | |
| 207 | Malonylation | TDVSTRYKVSTSPLT CCCCCEEEEECCCCH | 26.81 | 26320211 | |
| 209 | Phosphorylation | VSTRYKVSTSPLTKQ CCCEEEEECCCCHHC | 21.00 | 30108239 | |
| 210 | Phosphorylation | STRYKVSTSPLTKQL CCEEEEECCCCHHCC | 37.03 | 30266825 | |
| 211 | Phosphorylation | TRYKVSTSPLTKQLP CEEEEECCCCHHCCC | 15.48 | 29255136 | |
| 214 | Phosphorylation | KVSTSPLTKQLPTLI EEECCCCHHCCCEEE | 21.82 | 29255136 | |
| 215 (in isoform 1) | Ubiquitination | - | 58.48 | 21890473 | |
| 215 | Ubiquitination | VSTSPLTKQLPTLIL EECCCCHHCCCEEEE | 58.48 | 23000965 | |
| 224 | Ubiquitination | LPTLILFQGGKEAMR CCEEEEECCCHHHHH | 57.17 | 33845483 | |
| 227 | Ubiquitination | LILFQGGKEAMRRPQ EEEECCCHHHHHCCC | 49.47 | 21963094 | |
| 228 | Ubiquitination | ILFQGGKEAMRRPQI EEECCCHHHHHCCCC | 51.47 | 23503661 | |
| 231 | Ubiquitination | QGGKEAMRRPQIDKK CCCHHHHHCCCCCCC | 54.93 | 27667366 | |
| 231 (in isoform 2) | Ubiquitination | - | 54.93 | 21890473 | |
| 237 | 2-Hydroxyisobutyrylation | MRRPQIDKKGRAVSW HHCCCCCCCCCCCEE | 59.77 | - | |
| 241 | Ubiquitination | QIDKKGRAVSWTFSE CCCCCCCCCEEECCC | 14.36 | 33845483 | |
| 243 | Phosphorylation | DKKGRAVSWTFSEEN CCCCCCCEEECCCHH | 21.29 | 30266825 | |
| 245 | Phosphorylation | KGRAVSWTFSEENVI CCCCCEEECCCHHHH | 15.13 | 30266825 | |
| 247 | Phosphorylation | RAVSWTFSEENVIRE CCCEEECCCHHHHHH | 36.30 | 30266825 | |
| 255 (in isoform 2) | Ubiquitination | - | 10.15 | 21890473 | |
| 255 | Ubiquitination | EENVIREFNLNELYQ CHHHHHHCCHHHHHH | 10.15 | 33845483 | |
| 261 | Phosphorylation | EFNLNELYQRAKKLS HCCHHHHHHHHHHHH | 6.97 | 28152594 | |
| 265 | Ubiquitination | NELYQRAKKLSKAGD HHHHHHHHHHHHCCC | 57.33 | 33845483 | |
| 266 | Ubiquitination | ELYQRAKKLSKAGDN HHHHHHHHHHHCCCC | 57.94 | 23503661 | |
| 269 (in isoform 1) | Ubiquitination | - | 67.82 | 21890473 | |
| 269 | Ubiquitination | QRAKKLSKAGDNIPE HHHHHHHHCCCCCCC | 67.82 | 27667366 | |
| 276 | Ubiquitination | KAGDNIPEEQPVAST HCCCCCCCCCCCCCC | 66.52 | 33845483 | |
| 282 | Phosphorylation | PEEQPVASTPTTVSD CCCCCCCCCCCCCCC | 34.84 | 23401153 | |
| 283 | Phosphorylation | EEQPVASTPTTVSDG CCCCCCCCCCCCCCC | 18.21 | 30266825 | |
| 285 | Phosphorylation | QPVASTPTTVSDGEN CCCCCCCCCCCCCCC | 39.66 | 22167270 | |
| 286 | Phosphorylation | PVASTPTTVSDGENK CCCCCCCCCCCCCCC | 21.15 | 23401153 | |
| 288 | Phosphorylation | ASTPTTVSDGENKKD CCCCCCCCCCCCCCC | 37.49 | 29255136 | |
| 293 | Ubiquitination | TVSDGENKKDK---- CCCCCCCCCCC---- | 59.03 | 33845483 | |
| 293 (in isoform 1) | Ubiquitination | - | 59.03 | 21890473 | |
| 300 | Ubiquitination | KKDK----------- CCCC----------- | 33845483 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TMX2_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TMX2_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TMX2_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| NDUV3_HUMAN | NDUFV3 | physical | 26186194 | |
| NDUA7_HUMAN | NDUFA7 | physical | 26186194 | |
| NDUV3_HUMAN | NDUFV3 | physical | 28514442 | |
| NDUA7_HUMAN | NDUFA7 | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-243, AND MASSSPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-288, AND MASSSPECTROMETRY. | |